SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Neurocrine Analysis Finds 6-Point EQ-VAS Gain Clinically Relevant

An analysis by Neurocrine found that a 6-point improvement on the EQ-VAS is clinically relevant in tardive dyskinesia.

NBIX

Related stories